Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00869843 · ClinicalTrials.gov registry record · Phase 1
Study of Saline Linked Monopolar Surface Radiofrequency (RF) Ablation of Hepatic Tumors
A Phase 1 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 28
- Enrollment target
NCT00869843: Completed Phase 1 study, sponsored by Washington University School of Medicine.
NCT00869843 is a Phase 1 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 28 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (53% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00869843, a Phase 1 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 28 participants
- Enrollment target
Study Summary
* To determine the depth of coagulation which is possible in human liver tissue using the saline linked RF Surface ablation with the Tissue Link floating ball. * To determine the efficacy of the technique on surface liver tumors using saline linked RF surface ablati * To determine a safe (non-popping upper limit) of power per area that will permit a 1 cm depth of tissue destruction without inflow occlusion an da 2 cm depth with inflow occlusion.
Primary Outcome
On day of surgery
Interventions
- PROCEDURE RF Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2002-10 |
| Est. Completion | 2009-03 |
| Phase | Phase 1 |
What the finished NCT00869843 record still lists
NCT00869843 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (53% lower).
The record links to 0 conditions, and to 1 intervention - of which RF Ablation is the first listed.
NCT00869843 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00869843 about?
NCT00869843 is a clinical study titled "Study of Saline Linked Monopolar Surface Radiofrequency (RF) Ablation of Hepatic Tumors". * To determine the depth of coagulation which is possible in human liver tissue using the saline linked RF Surface ablation with the Tissue Link floating ball. * To determine the efficacy of the technique on surface liver tumors using saline linked RF surface ablati * To determine a safe (non-poppin...
What is the current status of trial NCT00869843?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 28 participants. The study started on 2002-10. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00869843?
The interventions under investigation include: RF Ablation (PROCEDURE).
Who is sponsoring clinical trial NCT00869843?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00869843's enrollment target sits among peer trials
28 1447th of 2000 higher than 538 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia